References

1. SFK. Spectaculaire toename ADHD (Spectacular increase in ADHD). Pharmaceutisch Weekblad 2007; 142(29)
2. SFK. Explosieve groei ADHD-middelen zet door (Explosive growth in ADHD drugs continues). Pharmaceutisch Weekblad 2008; 143(29/30)
3. SFK. Kosten antidepressiva flink gedaald (Cost of antidepressants falls sharply). Pharmaceutisch Weekblad 2009; 144(13)
4. Wohlfarth T, Kalverdijk L, Rademaker C, Schothorst P, Minderaa R, Gispen-de Wied C. Psychopharmacology for children: From off label use to registration. European Neuropharmacology 2009; 19(8):603-608
5. MCRN website. [LINK - - RED.] http://www.mcrn.nl/ [LINK - - RED.]
6. CBG-MEB website. [LINK - - RED.] http://www.cbg-meb.nl/cbg/en/default.htm [LINK - - RED.]
7. The Medicines Act [Dutch title: Geneesmiddelenwet]. [LINK - - RED.] http://www.overheid.nl/english/ [LINK - - RED.]
8. IGZ website. [LINK - - RED.] http://www.igz.nl/english/ [LINK - - RED.]
9. GGZ Nederland. Een Transparant Medicatiebeleid, Rapport over een transparanter medicatiebeleid in de Kinder- en Jeugdpsychiatrie (A transparent medication policy: report on a more transparent medication policy in child and adolescent psychiatry). 2002-190
10. Dutch Institute for Healthcare Improvement CBO. Evidence-based Richtlijnontwikkeling, Handleiding voor werkgroepleden (Evidence-based guideline development, manual for working group members). 2007

Page last edited by: 28-01-2013
Share this page through:
Leave a comment

Do you feel we can improve this page? Is something missing? Can't find what you're looking for? Please let us know!

Cancel

May we ask you to make a concise profile?

It's not required, but does help others to understand your involvement with the Knowledge Centre.

Important: this information will not be shown to non-registered users and will not be used in any other way without your express permission.

I am:

Cancel